Latest Undisclosed Funding Rounds
Funding announcements whose series or stage was not named. Round amounts and investor roles are shown where disclosed.
- Rounds
- 1,233 All time
- Disclosed funding
- $109.5B 711 disclosed amounts
- Median round
- $10M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| O Fights AI-powered email attacks with an agentic email security platform | $28M | Undisclosed | Cybersecurity | United States | Investors | |
| TL Thalo LabsCompany profile Provides AI-powered real-time diagnostics and service intelligence for HVAC systems Provides AI-powered real-time diagnostics and service intelligence for HVAC systems | Undisclosed | StrategicUndisclosed | AI | United States | Investors | |
| C CheckerCompany profile Provides a single API for financial institutions to access stablecoin liquidity, cross-border payments, and treasury globally Provides a single API for financial institutions to access stablecoin liquidity, cross-border payments, and treasury globally | $8M | Undisclosed | Fintech | United States | Investors | |
| H3 HawkEye 360Company profile Detects, geolocates, and characterizes RF signals using a commercial satellite constellation Detects, geolocates, and characterizes RF signals using a commercial satellite constellation | ≤$125M | Revolving credit facilityUndisclosed | Space tech | United States | Investors | |
| FB Forlong BiotechnologyCompany profile Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer | $17.5M | Pre-Series BUndisclosed | Biotech | China | Investors | |
| EI Eris InnovationsCompany profile IP licensing company developing exchange-traded futures and options products based on the Eris Methodology IP licensing company developing exchange-traded futures and options products based on the Eris Methodology | Undisclosed | StrategicUndisclosed | Fintech | United States | Investors | |
| VI Vortex ImagingCompany profile Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care Develops a compact computational ultrasound system for standardized 3D volumetric imaging at the point of care | $12M | Undisclosed | Healthtech | United States | Investors | |
| S SearchableCompany profile Tracks and improves brand visibility across AI-driven search engines to grow high-intent traffic for enterprise brands Tracks and improves brand visibility across AI-driven search engines to grow high-intent traffic for enterprise brands | $14M | Undisclosed | Enterprise software | United States | Investors | |
| B BlinkCompany profile Mobile-first employee experience platform connecting frontline workforces across hospitality, retail, and logistics Mobile-first employee experience platform connecting frontline workforces across hospitality, retail, and logistics | $17M | Undisclosed | Enterprise software | United States | Investors | |
| FT Full-Life TechnologiesCompany profile Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing | $150M | Series D+DebtUndisclosed | Biotech | China | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1EU Innovation Fund
Epyr, Reverion, H2SITE
18rounds0led - 2NVIDIA
Riverlane, Foresight, Hiverge
14rounds0led - 3Accel
Coast, Origin, Scimplify
12rounds3led - 4Andreessen Horowitz (a16z)
Conway Research, EliseAI, Thatch
12rounds2led - 5Innovate UK
Emerald, Go Eve, Adaptavate
10rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.